XML 45 R34.htm IDEA: XBRL DOCUMENT v2.4.0.6
AGREEMENTS WITH GLAXOSMITHKLINE (Details) (GlaxoSmithKline Agreements, USD $)
1 Months Ended 3 Months Ended
Oct. 31, 2009
Epigenetic therapeutics
Mar. 31, 2012
Asset Transfer Agreement
AGREEMENTS WITH GLAXOSMITHKLINE    
Period of collaborative agreements 5 years  
Deferred revenue recognized $ 2,545,000  
Period over which deferred revenue is recognized 5 years  
Deferred revenue recognized as development and license revenue   $ 1,430,000